SARS-CoV-2 pharmacologic therapies and their safety/ effectiveness according to level of evidence
Introduction: There is a pressing need for COVID-19 transmission control and effective treatments. We aim to evaluate the safety and effectiveness of SARS-CoV-2 pharmacologic therapies as of August 2, 2020 according to study level of evidence. Methods: PubMed, ScienceDirect, Cochrane Library, JAMA N...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12736
- Acceso en línea:
- https://doi.org/10.1016/j.ajem.2020.08.091
http://hdl.handle.net/20.500.12010/12736
- Palabra clave:
- SARS-CoV-2
COVID-19 Pharmacologic Treatments
Drug Effectiveness
Drug safety
COVID-19 Clinical Outcomes
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Acceso restringido